Baku 7° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
17:58
Death toll from Crans-Montana bar fire rises to 41
Other countries17:37
Iranian drone conducts reconnaissance over Gulf of Oman amid military drills
Region17:08
Italian foreign minister: Balkans should join EU before Ukraine
Other countries16:46
Tehran: EU military attaches must leave Iran immediately
Region16:34
Indonesia reauthorizes Grok after content restrictions
Other countries16:15
Munich Conference head calls for greater EU role in NATO's nuclear deterrent
Other countries15:56
Photo
Video
Train carrying Russian grain departs for Armenia from Bilajari station
Foreign policy15:42
Türkiye details social media restrictions for children
Region15:29